Stabilization of amyloidogenic immunoglobulin light chains by small molecules.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
23 04 2019
Historique:
pubmed: 12 4 2019
medline: 26 3 2020
entrez: 12 4 2019
Statut: ppublish

Résumé

In Ig light-chain (LC) amyloidosis (AL), the unique antibody LC protein that is secreted by monoclonal plasma cells in each patient misfolds and/or aggregates, a process leading to organ degeneration. As a step toward developing treatments for AL patients with substantial cardiac involvement who have difficulty tolerating existing chemotherapy regimens, we introduce small-molecule kinetic stabilizers of the native dimeric structure of full-length LCs, which can slow or stop the amyloidogenicity cascade at its origin. A protease-coupled fluorescence polarization-based high-throughput screen was employed to identify small molecules that kinetically stabilize LCs. NMR and X-ray crystallographic data demonstrate that at least one structural family of hits bind at the LC-LC dimerization interface within full-length LCs, utilizing variable-domain residues that are highly conserved in most AL patients. Stopping the amyloidogenesis cascade at the beginning is a proven strategy to ameliorate postmitotic tissue degeneration.

Identifiants

pubmed: 30971495
pii: 1817567116
doi: 10.1073/pnas.1817567116
pmc: PMC6486714
doi:

Substances chimiques

Amyloid 0
Immunoglobulin Light Chains 0

Banques de données

PDB
['6MG4', '6MG5']

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

8360-8369

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK046335
Pays : United States
Organisme : NIDDK NIH HHS
ID : R37 DK046335
Pays : United States
Organisme : NIH HHS
ID : S10 OD012289
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002550
Pays : United States

Déclaration de conflit d'intérêts

Conflict of interest statement: G.J.M., N.L.Y., and J.W.K. have submitted a patent application for the small-molecule kinetic stabilizers of Ig light chains.

Références

Amyloid. 1999 Sep;6(3):165-71
pubmed: 10524280
Biochemistry. 1999 Oct 19;38(42):14101-8
pubmed: 10529258
J Biomol Screen. 1999;4(2):67-73
pubmed: 10838414
Circulation. 2001 Oct 2;104(14):1594-7
pubmed: 11581134
J Biomol Screen. 2001 Dec;6(6):429-40
pubmed: 11788061
J Med Chem. 2002 Apr 11;45(8):1712-22
pubmed: 11931626
Science. 2003 Jan 31;299(5607):713-6
pubmed: 12560553
Acta Crystallogr D Biol Crystallogr. 1996 Nov 1;52(Pt 6):1058-66
pubmed: 15299564
Amyloid. 2006 Dec;13(4):236-49
pubmed: 17107884
Biophys Chem. 2008 Jun;135(1-3):25-31
pubmed: 18395318
Mol Cell Proteomics. 2008 Aug;7(8):1570-83
pubmed: 18474516
Blood. 2008 Sep 1;112(5):1931-41
pubmed: 18567838
Amyloid. 2009 Mar;16(1):1-8
pubmed: 19291508
J Biomol NMR. 2011 Sep;51(1-2):123-9
pubmed: 21947921
Proc Natl Acad Sci U S A. 2012 Jun 12;109(24):9629-34
pubmed: 22645360
Neurology. 2012 Aug 21;79(8):785-92
pubmed: 22843282
J Clin Oncol. 2012 Dec 20;30(36):4541-9
pubmed: 23091105
Curr Top Med Chem. 2012;12(22):2523-33
pubmed: 23339305
J Neurol. 2013 Nov;260(11):2802-14
pubmed: 23974642
J Virol. 2013 Nov;87(22):12471-80
pubmed: 24027321
JAMA. 2013 Dec 25;310(24):2658-67
pubmed: 24368466
Biophys Chem. 2015 Dec;207:13-20
pubmed: 26263488
Science. 2015 Nov 6;350(6261):674-7
pubmed: 26542570
Elife. 2015 Nov 18;4:e10935
pubmed: 26576950
Biochim Biophys Acta. 2016 Apr;1864(4):409-18
pubmed: 26802902
J Mol Biol. 2016 Oct 23;428(21):4280-4297
pubmed: 27569045
Blood. 2017 Jan 19;129(3):299-306
pubmed: 27856462
Amyloid. 2016 Dec;23(4):209-213
pubmed: 27884064
Blood. 2018 Feb 1;131(5):525-532
pubmed: 29101236
Sci Rep. 2017 Dec 1;7(1):16809
pubmed: 29196671
Biochemistry. 2017 Dec 19;56(50):6597-6614
pubmed: 29200282
Circ Heart Fail. 2018 Apr;11(4):e004769
pubmed: 29615436
Chemphyschem. 2018 Jul 17;19(14):1707-1710
pubmed: 29663694
Kidney Int Rep. 2017 Nov 28;3(3):530-541
pubmed: 29854961
N Engl J Med. 2018 Sep 13;379(11):1007-1016
pubmed: 30145929
Nat Rev Dis Primers. 2018 Oct 25;4(1):38
pubmed: 30361521
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):854-863
pubmed: 30598439
Biochem Biophys Res Commun. 1970 Dec 9;41(5):1287-9
pubmed: 4099001
Biochemistry. 1973 Nov 6;12(23):4620-31
pubmed: 4773847
Biochemistry. 1974 Aug 27;13(18):3816-27
pubmed: 4850760
Science. 1971 Nov 12;174(4010):712-4
pubmed: 5123421
Biotechniques. 1994 Sep;17(3):585-9
pubmed: 7818914
Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5446-50
pubmed: 8202506
Blood. 1998 Apr 15;91(8):2948-54
pubmed: 9531605
Biochem Biophys Res Commun. 1998 Oct 20;251(2):642-7
pubmed: 9792827

Auteurs

Gareth J Morgan (GJ)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037; gjmorgan@bu.edu jkelly@scripps.edu.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.

Nicholas L Yan (NL)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.

David E Mortenson (DE)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.

Enrico Rennella (E)

Department of Molecular Genetics, The University of Toronto, Toronto, ON M5S1A8, Canada.
Department of Biochemistry, The University of Toronto, Toronto, ON M5S1A8, Canada.
Department of Chemistry, The University of Toronto, Toronto, ON M5S1A8, Canada.

Joshua M Blundon (JM)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.

Ryan M Gwin (RM)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.

Chung-Yon Lin (CY)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.

Robyn L Stanfield (RL)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.

Steven J Brown (SJ)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.

Hugh Rosen (H)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037.

Timothy P Spicer (TP)

Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458.

Virneliz Fernandez-Vega (V)

Department of Molecular Medicine, The Scripps Research Institute, Jupiter, FL 33458.

Giampaolo Merlini (G)

Department of Molecular Medicine, University of Pavia, 27100 Pavia, Italy.
Amyloidosis Research and Treatment Center, Foundation Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, 27100 Pavia, Italy.

Lewis E Kay (LE)

Department of Molecular Genetics, The University of Toronto, Toronto, ON M5S1A8, Canada.
Department of Biochemistry, The University of Toronto, Toronto, ON M5S1A8, Canada.
Department of Chemistry, The University of Toronto, Toronto, ON M5S1A8, Canada.
Program in Molecular Medicine, The Hospital for Sick Children, Toronto, ON M5G1X8, Canada.

Ian A Wilson (IA)

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037.
The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037.

Jeffery W Kelly (JW)

Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA 92037; gjmorgan@bu.edu jkelly@scripps.edu.
Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037.
The Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, CA 92037.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH